Gelatinolytic activity of matrix metalloproteinase in tumor tissues correlates with the invasiveness of oral cancer

Clinical and Experimental Metastasis

Volumn 17, Issue 4, 1999, Pages 315-322

  Ikebe, Tetsuro ^a   Shinohara, Masanori ^a   Takcuchi, Hiroshi ^a   Beppu, Mahiro ^a   Kurahara, Shin Ichi ^a   Nakamura, Seiji ^a   Shirasuna, Kanemitsu ^a  

^a KYUSHU UNIVERSITY   (Japan)

Author keywords

Immunohistochemistry; MMP; Oral cancer; Zymography

Indexed keywords

GELATINASE B; MATRIX METALLOPROTEINASE; TISSUE INHIBITOR OF METALLOPROTEINASE 1;

ARTICLE; CANCER INVASION; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME ANALYSIS; ENZYME INHIBITION; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; METASTASIS; MOUTH CANCER; ZYMOGRAPHY;

EID: 0032879124     PISSN: 02620898     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1006642428826     Document Type: Article

References (16)

1. Mignatti P, Rifkin DB. Biology and biochemistry of proteinases in tumor invasion. Physiol Rev 1993; 73: 161-95.
2. Harada T, Shinohara M, Nakamura S et al. An immunohistochemical study of the extracellular matrix in oral squamous cell carcinoma and its association with invasive and metastatic potential. Virchow Archiv 1994; 424: 257-66.
3. Stetler-Stevenson WG, Aznavoorian S, Liotta A. Tumor cell interactions with the extracellular matrix during invasion and metastasis. Annu Rev Cell Biol 1993; 9: 541-73.
4. Shima I, Sasaguri Y, Kusukawa J et al. Production of matrix metalloproteinase-2 and metalloproteinase-3 related to malignant behavior of esophageal carcinoma. A clinicopathologic study. Cancer 1992; 70: 2747-53.
5. Kusukawa J, Sasaguri Y, Shima I et al. Expression of matrix metalloproteinase-2 related to lymph node metastasis of oral squamous cell carcinoma. A clinicopathologic study. Am J Clin Pathol 1993; 99: 18-23.
6. Rao JS, Yamamoto M, Mohaman S et al. Expression and localization of 92 kDa type IV collagenase/gelatinase B(MMP-9) in human glioma. Clin Exp Metastasis 1996; 14: 12-8.
7. Pyke C, Ralfkiaer E, Huhtala P et al. Localization of messenger RNA for Mr 72,000 and 92,000 type IV collagenases in human skin cancers by in situ hybridization. Cancer Res 1992; 52: 1336-41.
8. Davies B, Waxman J, Wasan H et al. Levels of matrix metalloproteases in bladder cancer correlate with tumor grade and invasion. Cancer Res 1993; 53: 5365-69.
9. Liabakk NB, Talbot T, Smith RA et al. Matrix metalloproteinase 2(MMP-2) and matrix metalloproteinase 9(MMP-9) type TV collagenases in colorectal cancer. Cancer Res 1996; 56: 190-96.
10. Nakagawa T, Kubota T, Kabuto M et al. Production of matrix metal-loproteinases and tissue inhibitor of metalloproteinases-1 by human brain tumors. J Neurosurg 1994; 81: 69-77.
11. Sier CFM, Kubben FJGM, Ganesh S et al. Tissue levels of matrix metalloproteinases MMP-2 and MMP-9 are related to the overall survival of patients with gastric carcinoma. Br J Cancer 1996; 74: 413-17.
12. Yamamoto E, Miyake A, Kohama O. Mode of invasion and lymph node metastasis in squamous cell carcinoma of the oral cavity. Head Neck Sure 1984; 6: 938-47.
13. Nomara H, Fujimoto N, Seiki M et al. Enhanced production of matrix metalloproteinases and activation of matrix metalloproteinase 2 (gelatinase A) in human gastric carcinoma. Int J Cancer 1996; 69: 9-16.
14. Charous SJ, Stricklin OP, Nanney LB et al. Expression of matrix metalloproteinases and tissue inhibitor of metalloproteinases in head and neck squamous cell carcinoma. Ann Otol Rhinol Laryngol 1997; 106: 271-278.
15. Nuovo GJ, MacConnell PB, Simsir A et al. Correlation of the in situ detection of polymerase chain reaction-amplified metalloproteinase complementary DNAs and their inhibitors with prognosis in cervical carcinoma, Cancer Res 1995; 55: 267-75.
16. Sutinen M, Kainulainen T, Hurskainen T et al. Expression of matrix metalloproteinases (MMP-1 and -2) and their inhibitors (TIMP-1, -2 and -3) in oral lichen planus, dysplasia, squamous cell carcinoma and lymph node metastasis. Br J Cancer 1998; 77: 2239-45.